Heart Disease in Women: The Cardiac Amyloid Blind Spot That Delays Diagnosis by Years
A new review finds that women with transthyretin amyloid cardiomyopathy face diagnostic delays of up to five years because sex-blind ...
Tag: tafamidis
ACO-SWITCH Trial to Track Serum Transthyretin After Tafamidis-to-Acoramidis Switch
A newly published protocol details ACO-SWITCH, a phase 4 single-arm study that will measure serum transthyretin changes in 50 adults ...
Tafamidis Tied to 74% Lower Death Risk in Matched Real-World Heart Amyloidosis Cohort
A matched real-world cohort analysis found that patients with transthyretin amyloid cardiomyopathy treated with tafamidis had a 74% lower risk ...
Tafamidis Helps More Heart Amyloid Patients Keep Their Walking Distance, Analysis Finds
A post hoc analysis of the ATTR-ACT trial found that 64 percent of tafamidis-treated patients maintained walking-distance stability at 12 ...
Tafamidis Cuts Cardiovascular Death and Hospitalization Risk for Up to 90 Months
A post hoc analysis of the ATTR-ACT trial and its long-term extension found continuous tafamidis treatment significantly reduced cardiovascular death ...
Early TTR Rise on Tafamidis Tied to Lower Death Risk in ATTR-CM Trial Analysis
A post hoc analysis of the ATTR-ACT trial found that early increases in TTR concentration after tafamidis treatment were associated ...
In Hereditary Heart Amyloidosis, Polyneuropathy Care Depends on Documentation Quality
A chart review of 54 patients with hereditary transthyretin amyloidosis found that only a third of coded polyneuropathy diagnoses were ...
Women Remain a Small Minority in Tafamidis-Treated Amyloid Heart Disease Cohort
A pooled analysis of 1924 tafamidis-treated patients found women made up 11.1 percent of the cohort, more often carried hereditary ...
Research report: Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy
A pooled real-world analysis of 1,924 patients with transthyretin amyloid cardiomyopathy treated with tafamidis found that outcomes in patients aged ...
Real-World Data Suggest Acoramidis Outperforms Tafamidis in Heart Amyloidosis
A retrospective US claims analysis found that newly treated ATTR-CM patients starting acoramidis had significantly lower risks of diuretic intensification ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!